Trubion Pharmaceuticals, Inc — Form D

Trubion Pharmaceuticals, Inc of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2009-09-04. The offering totals $10.0M, of which $10.0M was reported sold. Industry: Biotechnology.

Offering

Filed: 2009-09-04
Form: D
Accession: 0001298521-09-000002
Industry: Biotechnology
Exemptions: 06
Total offering: $10.0M
Amount sold: $10.0M
Minimum investment: $10.0M
Investors: 1
Date of first sale: 2009-09-01
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-67751

Issuer

Name: Trubion Pharmaceuticals, Inc
CIK: 0001298521
Entity type: Corporation
Jurisdiction: DELAWARE
Address: 2401 4TH AVENUE, SEATTLE, WA, 98121
Phone: 2068380500

Officers, directors & promoters (13)

Name	Role	Location
Lee R Brettman	Director	Sudbury, MA
Steven Gillis	Director	South San Francisco, CA
Patrick Heron	Director	Philadelphia, PA
Anders D Hove	Director	Salt Lake City, UT
David A Mann	Director	Seattle, WA
Samuel R Saks	Director	Redwood City, CA
David Schnell	Director	New York, NY
Peter Thompson	Director	Chanhassen, MN
Michelle Burris	Executive Officer	Seattle, WA
Kathleen M Deeley	Executive Officer	Seattle, WA
Kendall Mohler	Executive Officer	Seattle, WA
Scott Stromatt	Executive Officer	Seattle, WA
Peter Thompson	Executive Officer	Chanhassen, MN

More